OpenURL Connection Search

Select item for more details and to access through your institution.

Efficacy and safety of enoxaparin to prevent deep venous thrombosis after hip replacement surgery. Enoxaparin Clinical Trial Group.
Published in:
1994
By:
- Spiro, Theodore E.;
- Johnson, Gerhard J.;
- Christie, Michael J.;
- Lyons, Roger M.;
- MacFarlane, Donald E.;
- Blasier, Ralph B.;
- Tremaine, M. David;
- Spiro, T E;
- Johnson, G J;
- Christie, M J;
- Lyons, R M;
- MacFarlane, D E;
- Blasier, R B;
- Tremaine, M D
Publication type:
journal article
A comprehensive analysis of the effects of rivaroxaban on stroke or transient ischaemic attack in patients with heart failure, coronary artery disease, and sinus rhythm: the COMMANDER HF trial.
Published in:
European Heart Journal, 2019, v. 40, n. 44, p. 3593, doi. 10.1093/eurheartj/ehz427
By:
- Mehra, Mandeep R;
- Vaduganathan, Muthiah;
- Fu, Min;
- Ferreira, João Pedro;
- Anker, Stefan D;
- Cleland, John G F;
- Lam, Carolyn S P;
- Veldhuisen, Dirk J van;
- Byra, William M;
- Spiro, Theodore E;
- Deng, Hsiaowei;
- Zannad, Faiez;
- Greenberg, Barry
Publication type:
Article
Laboratory assessment of rivaroxaban: a review.
Published in:
Thrombosis Journal, 2013, v. 11, n. 1, p. 11, doi. 10.1186/1477-9560-11-11
By:
- Samama, Meyer Michel;
- Contant, Geneviève;
- Spiro, Theodore E.;
- Perzborn, Elisabeth;
- Le Flem, Lena;
- Guinet, Céline;
- Gourmelin, Yves;
- Rohde, Gabriele;
- Martinoli, Jean-Luc
Publication type:
Article
Subcutaneous Enoxaparin Once or Twice Daily Compared with Intravenous Unfractionated Heparin for Treatment of Venous Thromboembolic Disease.
Published in:
Annals of Internal Medicine, 2001, v. 134, n. 3, p. 191, doi. 10.7326/0003-4819-134-3-200102060-00009
By:
- Merli, Geno;
- Spiro, Theodore E.;
- Olsson, Carl-Gustav;
- Abildgaard, Ulrich;
- Davidson, Bruce L.;
- Eldor, Amiram;
- Elias, Darlene;
- Grigg, Andrew;
- Musset, Dominique;
- Rodgers, George M.;
- Trowbridge, Arthur A.;
- Yusen, Roger D.;
- Zawilska, Krystyna
Publication type:
Article
Enhancing the Quality of Rivaroxaban Exposure Estimates Using Prothrombin Time in the Absence of Pharmacokinetic Sampling.
Published in:
CPT: Pharmacometrics & Systems Pharmacology, 2019, v. 8, n. 11, p. 805, doi. 10.1002/psp4.12444
By:
- Solms, Alexander;
- Frede, Matthias;
- Berkowitz, Scott D.;
- Hermanowski‐Vosatka, Anne;
- Kubitza, Dagmar;
- Mueck, Wolfgang;
- Spiro, Theodore E.;
- Willmann, Stefan;
- Yan, Xiaoyu;
- Zhang, Liping;
- Garmann, Dirk
Publication type:
Article
Benefit-Risk of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness: Pooled Analysis From MAGELLAN and MARINER.
Published in:
2021
By:
- Raskob, Gary E.;
- Spyropoulos, Alex C.;
- Spiro, Theodore E.;
- Wentao Lu;
- Zhong Yuan;
- Levitan, Bennett;
- Eunyoung Suh;
- Barnathan, Elliot S.;
- Lu, Wentao;
- Yuan, Zhong;
- Suh, Eunyoung
Publication type:
journal article
Association Between Asymptomatic Proximal Deep Vein Thrombosis and Mortality in Acutely Ill Medical Patients.
Published in:
2021
By:
- Raskob, Gary E.;
- Spyropoulos, Alex C.;
- Cohen, Alexander T.;
- Weitz, Jeffrey I.;
- Ageno, Walter;
- De Sanctis, Yoriko;
- Wentao Lu;
- Jianfeng Xu;
- Albanese, John;
- Sugarmann, Chiara;
- Weber, Traci;
- Lipardi, Concetta;
- Spiro, Theodore E.;
- Barnathan, Elliot S.;
- Lu, Wentao;
- Xu, Jianfeng
Publication type:
journal article
Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in the prevention of venous thromboembolism.
Published in:
Journal of Thrombosis & Thrombolysis, 2020, v. 50, n. 1, p. 12, doi. 10.1007/s11239-020-02078-8
By:
- Reinecke, Isabel;
- Solms, Alexander;
- Willmann, Stefan;
- Spiro, Theodore E.;
- Peters, Gary;
- Weitz, Jeffrey I.;
- Mueck, Wolfgang;
- Garmann, Dirk;
- Schmidt, Stephan;
- Zhang, Liping;
- Fox, Keith A. A.;
- Berkowitz, Scott D.
Publication type:
Article
Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in the treatment of venous thromboembolism.
Published in:
Journal of Thrombosis & Thrombolysis, 2020, v. 50, n. 1, p. 1, doi. 10.1007/s11239-020-02073-z
By:
- Solms, Alexander;
- Willmann, Stefan;
- Reinecke, Isabel;
- Spiro, Theodore E.;
- Peters, Gary;
- Weitz, Jeffrey I.;
- Mueck, Wolfgang;
- Garmann, Dirk;
- Schmidt, Stephan;
- Zhang, Liping;
- Fox, Keith A. A.;
- Berkowitz, Scott D.
Publication type:
Article
Improved Benefit Risk Profile of Rivaroxaban in a Subpopulation of the MAGELLAN Study.
Published in:
Clinical & Applied Thrombosis/Hemostasis, 2019, v. 25, p. 1, doi. 10.1177/1076029619886022
By:
- Spyropoulos, Alex C.;
- Lipardi, Concetta;
- Jianfeng Xu;
- Wentao Lu;
- Eunyoung Suh;
- Zhong Yuan;
- Levitan, Bennett;
- Sugarmann, Chiara;
- De Sanctis, Yoriko;
- Spiro, Theodore E.;
- Barnathan, Elliot S.;
- Raskob, Gary E.
Publication type:
Article
Evaluation of the Prothrombin Time for Measuring Rivaroxaban Plasma Concentrations Using Calibrators and Controls: Results of a Multicenter Field Trial.
Published in:
Clinical & Applied Thrombosis/Hemostasis, 2012, v. 18, n. 2, p. 150, doi. 10.1177/1076029611426282
By:
- Samama, Meyer Michel;
- Contant, Genevieve;
- Spiro, Theodore E.;
- Perzborn, Elisabeth;
- Flem, Lena Le;
- Guinet, Céline;
- Gourmelin, Yves;
- Martinoli, Jean Luc
Publication type:
Article

Found: 11